Equity (Tables)
|
3 Months Ended |
Mar. 31, 2024 |
Mar. 31, 2023 |
| Stockholders' Equity Note [Abstract] |
|
|
| Schedule of stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
2024 |
|
2023 |
|
(U.S. $ in thousands) |
| Cost of revenues |
$ |
952 |
|
|
$ |
932 |
|
| Research and development, net |
2,131 |
|
|
2,089 |
|
| Selling, general and administrative |
5,566 |
|
|
5,220 |
|
| Total stock-based compensation expenses |
$ |
8,649 |
|
|
$ |
8,241 |
|
|
|
| Schedule of stock option activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Options |
|
|
Weighted Average Exercise Price |
| Options outstanding as of January 1, 2024 |
|
|
1,360,652 |
|
|
$ |
20.67 |
|
| Granted |
|
|
— |
|
|
|
— |
|
| Exercised |
|
|
(11,393) |
|
|
13.09 |
|
| Forfeited |
|
|
(51,826) |
|
|
21.87 |
|
| Options outstanding as of March 31, 2024 |
|
|
1,297,433 |
|
|
20.69 |
|
| Options exercisable as of March 31, 2024 |
|
|
965,417 |
|
|
|
$ |
22.25 |
|
|
|
| Schedule of RSUs and PSUs activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of RSUs and PSUs |
|
|
Weighted Average
Grant Date Fair Value |
| Unvested as of January 1, 2024 |
|
|
3,842,232 |
|
|
$ |
17.95 |
|
| Granted |
|
|
1,819,251 |
|
|
11.84 |
|
| Vested |
|
|
(772,939) |
|
|
19.63 |
|
| Forfeited |
|
|
(25,181) |
|
|
18.42 |
|
| Unvested as of March 31, 2024 |
|
|
4,863,363 |
|
|
$ |
15.40 |
|
|
|
| Schedule of accumulated other comprehensive loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2024 |
|
|
Net unrealized gain
(loss) on cash flow
hedges |
Foreign currency
translation
adjustments |
Total |
|
|
U.S. $ in thousands |
|
|
|
|
|
| Balance as of January 1, 2024 |
|
$ |
1,790 |
|
$ |
(8,869) |
|
$ |
(7,079) |
|
| Other comprehensive income (loss) before reclassifications |
|
1,493 |
|
(2,186) |
|
(693) |
|
| Amounts reclassified from accumulated other comprehensive loss |
|
(811) |
|
— |
|
(811) |
|
| Other comprehensive income (loss) |
|
682 |
|
(2,186) |
|
(1,504) |
|
| Balance as of March 31, 2024 |
|
$ |
2,472 |
|
$ |
(11,055) |
|
$ |
(8,583) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2023 |
|
|
Net unrealized gain
(loss) on cash flow
hedges |
Foreign currency
translation
adjustments |
Total |
|
|
U.S. $ in thousands |
|
|
|
|
|
| Balance as of January 1, 2023 |
|
$ |
(299) |
|
$ |
(12,519) |
|
$ |
(12,818) |
|
| Other comprehensive income (loss) before reclassifications |
|
(1,828) |
|
1,255 |
|
(573) |
|
| Amounts reclassified from accumulated other comprehensive loss |
|
(417) |
|
— |
|
(417) |
|
| Other comprehensive income (loss) |
|
(2,245) |
|
1,255 |
|
(990) |
|
| Balance as of March 31, 2023 |
|
$ |
(2,544) |
|
$ |
(11,264) |
|
$ |
(13,808) |
|
|